Business Wire

Global Foundation Launches to Accelerate an End to Smoking

Del

With the goal of eliminating smoking worldwide, the Foundation for a Smoke-Free World formally launched today in New York City. The Foundation is founded and led by Dr. Derek Yach, a renowned anti-smoking crusader who, while at the World Health Organization (WHO), was the primary architect of the WHO’s Framework Convention on Tobacco Control. The Foundation will build upon recent shifts in policy and science to fund research and support collaborative initiatives to accelerate progress in reducing harm and deaths from smoking worldwide.

“For decades, despite significant tobacco control initiatives, smoking has remained the world’s number one preventable cause of death. With more than one billion smokers, and one death every six seconds from smoking, there is an urgent need to accelerate progress and end this public health crisis,” said Dr. Yach, the Foundation’s founder and president-designate. “The Foundation for a Smoke-Free World will bring needed resources, expertise, fresh thinking, and a collaborative spirit to form partnerships, initiate dialogue, conduct research, and take actions to more rapidly rid the world of smoking and its negative health impacts.”

The Foundation has secured initial funding of approximately US$80 million annually over the next 12 years, beginning in 2018, from Philip Morris International (PMI). The Foundation is seeking and expects to receive funding from other sources as well. Importantly, the grant terms, bylaws, and non-profit status of the Foundation preclude PMI or other tobacco industry representatives from involvement in Foundation governance, or from having any influence over the Foundation’s funding decisions, strategy, or activities. The Foundation will have an independent research agenda, ownership of its data, freedom to publish, and strict protections against conflict of interest.

The Foundation’s ongoing activities and research priorities will be informed through a transparent public dialogue, and will be subject to the approval of an independent board of directors. Initial activities are expected to be focused in four areas of need:

  1. Support research into smoking harm reduction and build research capacity through academic centers of excellence
  2. Collaboratively build consensus around which interventions can best reduce harm and deaths from smoking and increase smoking cessation
  3. Measure and report on global progress towards smoking harm reduction
  4. Identify alternative crops and livelihoods for tobacco farmers as the global demand for tobacco declines

“The world needs to act with greater urgency and more creativity to cut the adult smoking rate and prevent cancer, heart disease and lung diseases,” said Dr. John Seffrin, professor of practice at Indiana University-Bloomington School of Public Health and past president of the Union for International Cancer Control. “The Foundation for a Smoke-Free World will bring new energy, needed resources and significant expertise to the fight. The Foundation will fund critical research to help eliminate gaps in science, and help the global community pick up the pace of progress in providing science-based solutions for the world’s one billion smokers, most of whom seek to quit cigarettes.”

The Foundation will also focus its efforts on understanding and helping to address disproportionate challenges and impacts associated with efforts to end smoking in developing countries. For example, the Foundation will work to help smallholder tobacco farmers shift to alternative crops.

“A decline in tobacco production creates an opportunity to solve food insecurity issues that exist in many parts of the world,” said Dyborn Chibonga, CEO of the National Smallholder Farmers’ Association of Malawi. “I look forward to helping the Foundation partner with public and private entities to develop practical solutions to these pressing problems.”

“It is time for new thinking and open, collaborative approaches that speed us closer to our shared goal,” said Dr. Yach. “We’ll need a multitude of approaches – encompassing behavioral and biological science, economics, policy, technology, pharmacology, epidemiology, and agricultural expertise – to develop the right approaches for different regions and cultures. If we work together, I’m confident we can end smoking throughout the world.”

For more information about the Foundation and its activities, or to review its bylaws and certificate of incorporation, please visit www.smoke-freeworld.org.

Editor’s note: Dr. Yach will formally announce the Foundation and outline its goals at 9:30 am EDT today, September 13, during a speech to the Global Tobacco & Nicotine Forum 2017 at the InterContinental New York Barclay in New York City. Dr. Yach will be preceded by Mitch Zeller, director of the US FDA's Center for Tobacco Products, who will speak at 8:45 am EDT about the need for a new approach to smoking cessation. Members of the media are invited to attend.

About the Foundation for a Smoke-Free World

The Foundation for a Smoke-Free World is an independent, non-profit organization dedicated to accelerating global efforts to reduce deaths and harm from smoking, with the ultimate goal of eliminating smoking worldwide. The Foundation also supports populations who are disproportionately burdened by a rapid transition away from smoking, with an initial focus on helping tobacco farmers in the developing world. For more information about the Foundation, please visit www.smoke-freeworld.org.

Contact information

for The Foundation for a Smoke-Free World
Tom Langford, 617-761-6775
tom.langford@fkhealth.com

Om Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

(c) 2018 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Følg saker fra Business Wire

Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra Business Wire

ABB Showcases World-Leading e-Vehicle Fast Chargers and Launches AI Readiness Index at Hannover22.4.2018 10:00Pressemelding

ABB spotlighted its world-leading Terra HP family of fast chargers for electric vehicles at Hannover Messe, the biggest global industrial trade fair. By operating at powers of up to 350 kilowatts and adding as much as 300 kilometers of range to an electric vehicle in just 12 minutes, the Terra HP family of chargers have made electric cars more appealing for consumers by enabling them to refresh the batteries in about the same time required for filling up a petrol-powered car. Terra HP chargers are being installed around the world, and they have been selected for use by Electrify America, the biggest electric vehicle infrastructure project to date in the United States. ABB, whose broad array of digitally driven technologies for electric-power management are used by utilities and businesses worldwide, is also a global leader in industrial automation and robots enabled by artificial intelligence (AI). Demonstrating its commitment to helping the international community address the opportun

PSE: APM Forum 2018 Focus on Digitalisation for the Process Industries20.4.2018 15:13Pressemelding

At the 2018 Advanced Process Modelling (APM) Forum this week, process industry organisations presented on digital design and operations applications ranging from accelerating development of the next generation of pharmaceuticals to realising millions of dollars per year in increased profit for large process plants. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180420005517/en/ Ben Weinstein, head of R&D Product and Process Systems Modeling at Procter & Gamble, delivers the keynote speech on how digital design techniques are used systematically to accelerate innovation in P&G. (Photo: Business Wire) Introducing the conference, Prof. Costas Pantelides, MD of conference host Process Systems Enterprise (PSE), described the current wave of digitalisation as the culmination of many years of advanced modelling and IT development. “This is a time of extraordinary opportunities for the process industries” he said. Keynote speaker Ma

Aperta Provides Electronic Funds Transfer (EFT) in Cayman Islands20.4.2018 14:01Pressemelding

Once again, the Aperta Active Clearing System (ACS) has delivered the mechanism for a country to implement a world-class electronic payment processing environment to maximize a national payments system’s efficiency, effectiveness, security and control. Aperta partnered with the Cayman Islands ACH Operator (Prism Services (Cayman) Ltd.) and local commercial banks to deliver a new Electronic Funds Transfer system. The old process of banks swapping files in a wide-variety of standards and settling bilaterally has been replaced with a common system and standards, employing international-standard secure file transfer protocol, allowing participants to monitor real time net settlement and collateral positions via a secure portal. The Cayman Islands Automated Clearinghouse (CIACH) links all six of the country’s banks and provides the central clearing and settlement mechanism for banks to exchange direct debit and direct credit transactions seamlessly across the country. It is functionally NAC

FII Tech Growth Invests in SECO20.4.2018 13:39Pressemelding

FII Tech Growth, a fund managed by Fondo Italiano d’Investimento SGR, announces today its second investment in SECO SpA, one of the European leaders in the embedded electronics market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180420005413/en/ (Photo: SECO) SECO, headquartered in Arezzo, Tuscany, with subsidiaries in the U.S.A., Germany and Taiwan, was founded in 1979 by entrepreneurs Daniele Conti and Luciano Secciani. The company designs and manufactures micro-computers and integrated systems for industrial applications. With more than 250 employees, SECO supports customers with a worldwide presence such as Cimbali, Esaote, Technogym and Vimar, and generated revenue in excess of Euro 50 million in 2017. The ability to offer innovative solutions by using cutting-edge technologies has allowed SECO to grow steadily over time. The company developed a network of collaborations with universities and research centres La Sapi

Schlumberger Announces First-Quarter 2018 Results20.4.2018 11:05Pressemelding

Schlumberger Limited (NYSE:SLB) today reported results for the first quarter of 2018. (Stated in millions, except per share amounts) Three Months Ended Change Mar. 31, 2018 Dec. 31, 2017 Mar. 31, 2017 Sequential Year-on-year Revenue $7,829 $8,179 $6,894 -4% 14% Pretax operating income $974 $1,155 $757 -16% 29% Pretax operating margin 12.4% 14.1% 11.0% -169 bps 145 bps Net income (loss) - GAAP basis $525 $(2,255) $279 n/m 88% Net income, excluding charges & credits* $525 $668 $347 -21% 51% Diluted EPS (loss per share) - GAAP basis $0.38 $(1.63) $0.20 n/m 90% Diluted EPS, excluding charges & credits* $0.38 $0.48 $0.25 -21% 52% *These are non-GAAP financial measures. See section below entitled "Charges & Credits" for details. n/m = not meaningful Schlumberger Chairman and CEO Paal Kibsgaard commented, “As forecast, our results in the first quarter of 2018 largely reflected transitory factors, with seasonal reductions in activity in the Northern Hemisphere and planned project startup costs

Biogen and Ionis Expand Strategic Collaboration to Develop Drug Candidates for a Broad Range of Neurological Diseases20.4.2018 10:30Pressemelding

Biogen (Nasdaq: BIIB) and Ionis Pharmaceuticals (Nasdaq: IONS) announced today they have expanded their strategic collaboration through a new ten-year collaboration agreement to develop novel antisense drug candidates for a broad range of neurological diseases. This collaboration capitalizes on Biogen’s expertise in neuroscience research and drug development and Ionis’ leadership in RNA targeted therapies with the goal of developing a broad pipeline of investigational therapies. It builds upon a productive collaboration that produced SPINRAZA, the first and only approved treatment for patients with spinal muscular atrophy. Today, April 20, 2018, Biogen and Ionis will host company conference calls and webcasts to discuss the new collaboration. Full webcast details can be found below. Under the terms of the collaboration, Biogen will pay Ionis $1 billion in cash, which will include $625 million to purchase 11,501,153 shares of Ionis common stock at a price of $54.34 per share, at an appr